Timing of SGLT2i initiation after acute myocardial infarction

BACKGROUND: Pharmacological post-MI treatment is routinely initiated at intensive/cardiac care units. However, solid evidence for an early start of these therapies is only available for dual platelet therapy and statins, whereas data on beta blockers and RAAS inhibitors are heterogenous and mainly l...

Descripción completa

Detalles Bibliográficos
Autores principales: von Lewinski, Dirk, Kolesnik, Ewald, Aziz, Faisal, Benedikt, Martin, Tripolt, Norbert J., Wallner, Markus, Pferschy, Peter N., von Lewinski, Friederike, Schwegel, Nora, Holman, Rury R., Oulhaj, Abderrahim, Moertl, Deddo, Siller-Matula, Jolanta, Sourij, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544140/
https://www.ncbi.nlm.nih.gov/pubmed/37777743
http://dx.doi.org/10.1186/s12933-023-02000-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544140/
https://www.ncbi.nlm.nih.gov/pubmed/37777743
http://dx.doi.org/10.1186/s12933-023-02000-5

Ejemplares similares